JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, T. H.
Right arrow Articles by Trendelenburg, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, T. H.
Right arrow Articles by Trendelenburg, U.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 2, 310-324, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF DOPAMINE AND agr-METHYL-DOPAMINE ON SMOOTH MUSCLE AND ON THE CARDIAC PACEMAKER

T. H. Tsai 1, S. Z. Langer 1, and U. Trendelenburg 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

The action of dopamine and agr-methyl-dopamine was studied on the nictitating membrane of the spinal cat and on the pacemaker of isolated guinea-pig atria. In both organs, dopamine had direct (reserpine-resistant) and indirect (reserpine-sensitive) effects. The introduction of an agr-methyl group decreased the potency of the direct and increased the indirect effects. The agr-methylated derivatives appear to be more potent releasers of norepinephrine than the non-methylated amines, probably because the former are not metabolized by intraneuronal monoaminoxidase. Chronic decentralization of the nictitating membrane increased the sensitivity to both amines equally and moderately. Chronic denervation and cocaine, on the other hand, potentiated dopamine much more than agr-methyl-dopamine. No evidence was obtained for the view that the conversion of either of the amines to norepinephrine and agr-methyl-norepinephrine, respectively, contributes to the pharmacologic responses obtained by injections or infusions of the parent amines. On the other hand, evidence was obtained for the view that dopamine not only releases endogenous norepinephrine but also prevents the reuptake of the released transmitter. Consequently, at least three different mechanisms contribute to a pharmacologic response to dopamine: 1) a direct action on the agr-receptors (nictitating membrane) or beta-receptors (pacemaker), 2) a release of endogenous norepinephrine, and 3) an impairment of the reuptake of the released norepinephrine. It also appears likely that during a continuous infusion of dopamine into a spinal cat, a gradual increase of the amine at the receptors of the innervated nictitating membrane takes place, presumably because of a gradually increasing saturation of the uptake mechanism for dopamine.

Submitted on September 15, 1966
Accepted on November 16, 1966




This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
E. Shahar, D. Lotan, and Z. Barzilay
Dopamine-induced Paroxysmal Supraventricular Tachycardia in an Infant
Clinical Pediatrics, August 1, 1981; 20(8): 541 - 543.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.